We are live on !
Find out more
ACR Alpine Capital Research Portfolio holdings
AUM
$7.04B
Turnover
19.51%
1-Year Est. Return
28%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+28%
3 Year Est. Return
+58.09%
5 Year Est. Return
+55.24%
10 Year Est. Return
+208.51%
AUM
$7.04B
AUM Growth
+$346M
(+5.2%)
Cap. Flow
+$125M
Cap. Flow % of AUM
Cap. Flow %
1.77%
Top 10 Holdings %
Top 10 Hldgs %
70.37%
Holding
41
New
5
Increased
16
Reduced
14
Closed
3
Avg Time Held
5.3
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
6.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$274M |
| 2 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$238M |
| 3 |
Dollar General
DG
|
+$68.7M |
| 4 |
Microsoft
MSFT
|
+$62.6M |
| 5 |
Thor Industries
THO
|
+$48.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arrow Electronics
ARW
|
+$423M |
| 2 |
Citigroup
C
|
+$191M |
| 3 |
Vodafone
VOD
|
+$43M |
| 4 |
Dell
DELL
|
+$16.8M |
| 5 |
People Inc
PPLI
|
+$6.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.45% |
| 2 | Miscellaneous | 19.53% |
| 3 | Healthcare | 11.87% |
| 4 | Financials | 11.66% |
| 5 | Technology | 10.79% |
Similar funds
ACR Alpine Capital Research's Q2 2026 Portfolio in Review
As of Q2 2026, ACR Alpine Capital Research held 41 positions worth $7.04B, up 5.2% from $6.7B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
ACR Alpine Capital Research's Q2 2026 filing shows 5 new, 16 increased, 14 reduced and 3 closed positions. Its largest new stake was Elevance Health: 737,922 shares worth $285M. The largest sale was Arrow Electronics, an estimated $423M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 20% a quarter earlier, followed by Miscellaneous and Healthcare.
- ACR Alpine Capital Research's largest Q2 2026 buy was Elevance Health: 737,922 shares worth $285M.
- ACR Alpine Capital Research added most to Goldman Sachs Access Treasury 0-1 Year ETF in Q2 2026, an estimated $238M increase.
- ACR Alpine Capital Research's biggest Q2 2026 reduction was Arrow Electronics, cutting an estimated $423M.
- ACR Alpine Capital Research fully exited Diamond Hill in Q2 2026, selling an estimated $4.09M.
- ACR Alpine Capital Research's ten largest holdings make up 70% of its $7.04B portfolio in Q2 2026.
- ACR Alpine Capital Research opened 5 new positions and closed 3 in Q2 2026.
- ACR Alpine Capital Research's portfolio value rose 5.2% quarter-over-quarter to $7.04B.
Based on ACR Alpine Capital Research's 13F filing for Q2 2026, filed 29 Jul 2026.